HagaZiekenhuis - Locatie Leyweg
About HagaZiekenhuis - Locatie Leyweg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Commissie Voor Klinisch Toegepast Onderzoek
4
Abbott Medical Devices
3
European Organisation for Research and Treatment of Cancer - EORTC
3
Medtronic Cardiac Rhythm and Heart Failure
3
Boston Scientific Corporation
2
Hoffmann-La Roche
2
Medtronic Vascular
2
Wageningen University
2
Amgen
1
Medtronic
1
Medtronic Cardiovascular
1
Clinical Trials at HagaZiekenhuis - Locatie Leyweg
During the past decade, HagaZiekenhuis - Locatie Leyweg conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
2000-09-01
2007-10-01
Completed
340
Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer
2001-02-01
2013-03-01
Completed
4,813
Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-02-01
Unknown status
400
Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
2001-04-01
Unknown status
60
Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma
2001-03-01
Unknown status
450
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
2002-05-01
Unknown status
220
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
2002-08-01
Completed
552
Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality
2002-04-01
2010-06-01
Completed
4,837
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "HagaZiekenhuis - Locatie Leyweg" #1 sponsor was "Commissie Voor Klinisch Toegepast Onderzoek" with 4 trials, followed by "Abbott Medical Devices" with 3 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored and "Boston Scientific Corporation"
with 3 trials sponsored. Other sponsors include 5 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "HagaZiekenhuis - Locatie Leyweg"
#1 collaborator was "ALMANAC Trialists Group" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Borstkanker Onderzoeksgroup Nederland" with 1 trials as a collaborator and "Grup per l'Estudi dels Limfomes de Catalunya i Balears" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at HagaZiekenhuis - Locatie Leyweg
According to Clinical.Site data, the most researched conditions in "HagaZiekenhuis - Locatie Leyweg" are
"Coronary Artery Disease" (4 trials), "Lymphoma" (3 trials), "Leukemia" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Aortic Valve Replacement" (1 trials). Many other conditions were trialed in "HagaZiekenhuis - Locatie Leyweg" in a lesser frequency.
Clinical Trials Intervention Types at HagaZiekenhuis - Locatie Leyweg
Most popular intervention types in "HagaZiekenhuis - Locatie Leyweg" are "Device" (11 trials), "Drug" (10 trials), "Biological" (4 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "filgrastim" (4 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "vincristine sulfate" (3 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at HagaZiekenhuis - Locatie Leyweg
The vast majority of trials in "HagaZiekenhuis - Locatie Leyweg" are
24 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at HagaZiekenhuis - Locatie Leyweg
Currently, there are NaN active trials in "HagaZiekenhuis - Locatie Leyweg".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in HagaZiekenhuis - Locatie Leyweg,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in HagaZiekenhuis - Locatie Leyweg, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 9 trials that are defined as “Not Applicable".